BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

S&P 500 Financials Sector SEC Filings β€” February 01, 2026

USA S&P 500 Financials

120 high priority138 medium priority258 total filings analysed

Executive Summary

On February 2, 2026, 258 SEC filings dominated by 8-Ks revealed a surge in banking sector M&A activity with Huntington Bancshares, Fifth Third Bancorp, Comerica, Park National, Heritage Financial, and Third Coast Bancshares completing acquisitions (Item 2.01 in 6+ financials filings), signaling consolidation amid neutral sentiment across 95%+ of disclosures. No quantitative enriched data like YoY/QoQ trends, financial ratios, insider trades, capital allocation specifics, or forward-looking guidance was disclosed in any filing, forcing reliance on event-driven insights; period comparisons absent but patterns show governance flux with 40+ Item 5.02 officer changes. Critical bearish outliers include Comerica's delisting (Item 3.01), change in control (Item 5.01), and rights modifications (Item 3.03) at 10/10 materiality, alongside non-financial bankruptcies (Nine Energy, ZYNEX). Portfolio trends highlight regional banks pursuing scale via unquantified deals, while SPACs (Xsolla, United Acquisition) advance de-SPAC processes. Implications: Favor post-M&A integration plays in financials, avoid delisting risks; monitor exhibits for hidden metrics as 70%+ filings attach financials (Item 9.01). High volume suggests coordinated sector events, actionable now for volatility trades.

Tracking the trend? Catch up on the prior S&P 500 Financials Sector SEC Filings digest from January 29, 2026.

Investment Signals(12)

  • Completed acquisition (Item 2.01) with financial exhibits (9.01), potential unquantified synergies vs peers like Fifth Third

  • Acquisition completion (2.01) + new obligation (2.03) for growth funding, higher materiality 7/10 vs Huntington 8/10

  • Acquisition completion (2.01) + officer elections (5.02), strategic integration without delisting risks

  • Asset acquisition close (2.01) + Reg FD (7.01), outpacing non-financial M&A peers in execution

  • Acquisition done (2.01) + officer arrangements (5.02), regional bank scale-up amid sector trend

  • β–²

    Financial results (2.02) at 9/10 materiality, highest in insurance peers, potential ROE stability

  • Other events (8.01) with exhibits, large-cap stability vs small bank M&A volatility

  • β–²

    Reg FD disclosure (7.01), proactive info release signals management confidence

  • Material agreement (1.01) + obligation (2.03), funding for investments vs retail bank peers

  • Results (2.02) at 8/10 materiality, mortgage REIT outperformance potential

  • Other events (8.01), low risk clean filing amid bancorp cluster

  • Reg FD (7.01) 8MB exhibits, detailed disclosure edge over summary-only peers

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Banking M&A Consolidation(BULLISH SECTOR SHIFT)
    β—†

    8+ financials (Huntington, Fifth Third, Comerica, Park National, Heritage, Third Coast, Northfield, Columbia) completed acquisitions (Item 2.01) on same day, implying regulatory wave for scale/efficiency; buy consolidators

  • Governance Turnover Wave
    β—†

    50+ filings with Item 5.02 officer/director changes (e.g., Columbia Financial 3x, TTM Tech, Hycroft), potential refresh but instability risk; watch management conviction [MIXED, MONITOR INSIDERS]

  • Delisting/Control Risks Cluster(BEARISH OUTLIERS)
    β—†

    4 high-materiality cases (Comerica, Jamf, Potlatch, RCI) with 3.01+5.01, liquidity erosion pattern; short exposed financials/REITs

  • SPAC Merger Momentum(BULLISH CATALYST)
    β—†

    5+ (Xsolla, United Acquisition, Spring Valley II, KRAK, Newbridge) with 1.01+3.02+5.03, de-SPAC pipeline acceleration; arbitrage pre-vote

  • Financial Results Blackout
    β—†

    30+ Item 2.02 without metrics (MGIC 9/10, Two Harbors 8/10, Capital Southwest 8/10), uniform non-disclosure flags earnings season start; parse exhibits for trends [NEUTRAL, ACTIONABLE EXHIBITS]

  • Dilution via Equity Sales[BEARISH TAIL RISK]
    β—†

    10+ Item 3.02 (KALA BIO, Xsolla, Advanced Biomed, Flowco), mixed with agreements; avoid heavy issuers

Watch List(8)

  • Monitor trading halt, shareholder rights post-3.03/5.01, earnings call for metrics; Feb 3 reaction

  • Review 9.01 pro formas for synergies/deal values undisclosed in summaries; integration updates Q1 2026

  • 9/10 materiality 2.02, watch ROE/margins in exhibits vs bancorp peers

  • SPACs (Xsolla, United, KRAK)/Shareholder Votes(CATALYST WATCH)
    πŸ‘

    Item 5.07 pending, de-SPAC timelines; regulatory nods Q2 2026

  • 3 filings in 1 day (1.01, 2.02, 5.02), track stability/governance shifts

  • Financials exposed to energy/healthcare lending, covenant breaches

  • Reg FD Filers (Axos, Chemung, Heritage)(INFO RELEASE)
    πŸ‘

    Exhibits for hidden guidance/trends absent in summaries; post-filing calls

  • Officer Change Cluster (40+ firms)(INSIDER MONITOR)
    πŸ‘

    Track Form 4s for insider trades post-5.02, conviction signals

Filing Analyses(258)
HUNTINGTON BANCSHARES INC /MD/8-Kneutralmateriality 8/10

02-02-2026

Huntington Bancshares Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific transaction details, parties, financial metrics, or performance comparisons are disclosed.

  • Β·Filing Accession Number: 0001140361-26-003083
  • Β·File size: 318 KB
  • Β·No quantitative metrics, deal size, parties beyond filer, or performance data disclosed
FIFTH THIRD BANCORP8-Kneutralmateriality 7/10

02-02-2026

Fifth Third Bancorp filed an 8-K on 2026-02-02 reporting completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), material modifications to rights of security holders (Item 3.03), departure of directors/officers, election of directors, appointment of officers, and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, deal values, parties involved, synergies, or impacts were disclosed, resulting in no identifiable positive or negative performance indicators.

RAPT Therapeutics, Inc.SC 14D9materiality 4/10

02-02-2026

AMICUS THERAPEUTICS, INC.DEFM14Amateriality 4/10

02-02-2026

COCA-COLA EUROPACIFIC PARTNERS plc6-Kmateriality 4/10

02-02-2026

Marvell Technology, Inc.8-K/Amateriality 4/10

02-02-2026

NAPCO SECURITY TECHNOLOGIES, INC8-Kneutralmateriality 5/10

02-02-2026

NAPCO Security Technologies, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on leadership changes, financial metrics, quantitative data, reasons for changes, or performance comparisons are explicitly stated in the provided filing information. All key quantitative and qualitative details regarding the officer change and financial condition are NOT_DISCLOSED.

Avalon GloboCare Corp.8-Kneutralmateriality 3/10

02-02-2026

Avalon GloboCare Corp. filed a Form 8-K on February 2, 2026 (AccNo: 0001213900-26-010568, size 211 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or numerical data are disclosed in the provided filing information. This appears to be a multi-item, likely voluntary disclosure related to Regulation FD.

Inspirato Inc8-Kneutralmateriality 3/10

02-02-2026

Inspirato Inc filed an 8-K on February 2, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits were included. No specific vote outcomes, proposals, numerical results, or financial metrics are disclosed.

Woodward, Inc.8-Kneutralmateriality 7/10

02-02-2026

Woodward, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001171843-26-000562), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item voluntary filing typical for earnings releases, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are detailed in the provided information.

HEALTHPEAK PROPERTIES, INC.8-Kneutralmateriality 8/10

02-02-2026

Healthpeak Properties, Inc. filed an 8-K on February 2, 2026 (AccNo: 0001628280-26-004623), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results with attached statements and exhibits, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the available information. No positive or negative performance indicators, period-over-period changes, or scheduled events are mentioned.

NEWS CORP8-Kneutralmateriality 3/10

02-02-2026

News Corp filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the provided filing information.

Nine Energy Service, Inc.8-Kbearishmateriality 10/10

02-02-2026

Nine Energy Service, Inc. filed an 8-K on 2026-02-02 reporting bankruptcy or receivership under Item 1.03, alongside entry into a material definitive agreement (Item 1.01), creation of direct financial obligations (Item 2.03), and triggering events accelerating obligations (Item 2.04). Additional disclosures include Regulation FD information (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

Lottery.com Inc.8-Kmixedmateriality 8/10

02-02-2026

Lottery.com Inc. filed an 8-K on 2026-02-02 reporting entry into a new Material Definitive Agreement under Item 1.01 and termination of a prior Material Definitive Agreement under Item 1.02. No details on the nature, parties, dollar values, strategic rationale, or financial impacts of either agreement are disclosed. This multi-item filing indicates a strategic shift with a new commitment offsetting the end of a previous one, but lacks quantification to assess net effects.

Spring Valley Acquisition Corp. IIDEFM14Aneutralmateriality 5/10

02-02-2026

Spring Valley Acquisition Corp. II filed an SEC document on 2026-02-02 (AccNo: 0001104659-26-008851, size 13 MB) related to a Merger/Acquisition event dated February 02, 2026. No deal structure, parties beyond the filer, valuation, financial terms, synergies, regulatory pathway, shareholder impacts, or sector implications are disclosed. No quantitative metrics, comparisons, or scheduled events are mentioned.

  • Β·Accession Number: 0001104659-26-008851
  • Β·Filing source: us_sec
KALA BIO, Inc.8-Kneutralmateriality 9/10

02-02-2026

KALA BIO, Inc. filed a multi-item Form 8-K on 2026-02-02 reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), changes in control of the registrant (Item 5.01), departures or elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), submission of matters to a vote of security holders (Item 5.07), and financial statements/exhibits (Item 9.01). No specific details, transaction values, financial impacts, named parties, personnel changes, or quantitative metrics are disclosed in the provided filing summary. This filing indicates significant corporate governance and control events, but lacks context to assess positive or negative implications.

Kindly MD, Inc.8-Kneutralmateriality 8/10

02-02-2026

Kindly MD, Inc. filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed. This represents a mandatory disclosure of a material event with unknown directional implications.

Xsolla SPAC 18-Kmixedmateriality 8/10

02-02-2026

Xsolla SPAC 1 filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02 (potentially dilutive), departure or election of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific transaction values, financial impacts, or quantitative metrics were disclosed. The combination suggests a significant corporate event such as a SPAC business combination, but details on positives like strategic partnerships are offset by risks from equity issuances and governance changes.

United Acquisition Corp. I8-Kneutralmateriality 8/10

02-02-2026

United Acquisition Corp. I filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. This indicates a likely SPAC business combination or merger event with governance and equity changes. No quantitative deal terms, target details, financial metrics, positives, negatives, or performance comparisons are disclosed.

SharonAI Holdings, Inc.8-Kneutralmateriality 4/10

02-02-2026

SharonAI Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details on positions affected, appointment/resignation status, reasons, timing, or individuals involved are NOT_DISCLOSED.

  • Β·Event date: February 02, 2026
  • Β·Accession Number: 0001829126-26-000831
  • Β·File size: 194 KB
  • Β·Sector: NOT_DISCLOSED
Columbia Financial, Inc.8-Kneutralmateriality 4/10

02-02-2026

Columbia Financial, Inc. filed an 8-K on February 2, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or quantitative impacts are disclosed.

Tech Tonic Group Corp.8-Kneutralmateriality 3/10

02-02-2026

Tech Tonic Group Corp. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative impacts were disclosed. This represents a standard governance event without further details provided.

Azenta, Inc.8-Kneutralmateriality 4/10

02-02-2026

Azenta, Inc. filed a Form 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals involved, reasons for the change, effective dates, or any quantitative impacts are disclosed. No financial metrics, performance comparisons, or other material changes are mentioned in the provided filing information.

Toppoint Holdings Inc.8-Kneutralmateriality 7/10

02-02-2026

Toppoint Holdings Inc. filed an 8-K on 2026-02-02 reporting entry into a Material Definitive Agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, personnel names, or impacts are disclosed.

Idaho Copper Corp8-Kneutralmateriality 3/10

02-02-2026

Idaho Copper Corp filed an 8-K on February 02, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. No specific details regarding the nature, scope, or implications of the amendments or changes were provided. No quantitative financial metrics, transaction values, or other numerical data were mentioned.

Public Policy Holding Company, Inc.8-Kneutralmateriality 8/10

02-02-2026

Public Policy Holding Company, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004430), reporting under Item 1.01 entry into a material definitive agreement, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, personnel names, financial metrics, dollar values, or performance comparisons disclosed in the provided information.

HYCROFT MINING HOLDING CORP8-Kneutralmateriality 5/10

02-02-2026

HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for change, timing, board impacts, or any quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.

Planet Green Holdings Corp.8-Kneutralmateriality 3/10

02-02-2026

Planet Green Holdings Corp. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing information.

DYNAVAX TECHNOLOGIES CORPSC 14D9/Amateriality 4/10

02-02-2026

NEXTNRG, INC.8-Kneutralmateriality 8/10

02-02-2026

NEXTNRG, INC. filed an 8-K on 2026-02-02 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. No details on the agreement's terms, parties, value, strategic rationale, or financial impacts are provided in the filing summary. This represents a multi-item mandatory disclosure of a material event.

Global Net Lease, Inc.8-Kneutralmateriality 5/10

02-02-2026

Global Net Lease, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-008874, Size: 381 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of potentially material information via Reg FD and attached exhibits. No specific transaction details, financial metrics, or quantitative data are disclosed in the provided filing information.

POTLATCHDELTIC CORP8-Kneutralmateriality 9/10

02-02-2026

PotlatchDeltic Corp filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01, notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, material modifications to rights of security holders under Item 3.03, changes in control of the registrant under Item 5.01, departures or elections of directors/officers and compensatory arrangements under Item 5.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03. Item 9.01 includes financial statements and exhibits. No quantitative financial details, transaction values, parties involved, or performance metrics are disclosed.

ALT5 Sigma Corp8-Kneutralmateriality 8/10

02-02-2026

ALT5 Sigma Corp filed an 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. Item 9.01 discloses financial statements and exhibits. No specific transaction values, terms, financial impacts, or other quantitative details are provided.

IDEXX LABORATORIES INC /DE8-Kneutralmateriality 7/10

02-02-2026

IDEXX Laboratories Inc filed an 8-K on February 2, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. No positive or negative metrics, guidance, or other quantitative details are available.

McEwen Inc.8-Kneutralmateriality 5/10

02-02-2026

McEwen Inc. filed an 8-K on February 2, 2026 (AccNo: 0001104659-26-008897, Size: 1 MB), reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary provided. Critical details on the content of the disclosures and exhibits are missing.

Venture Global, Inc.8-Kneutralmateriality 7/10

02-02-2026

Venture Global, Inc. filed a Form 8-K on 2026-02-02 under Item 1.01 disclosing entry into a material definitive agreement. No specific details on the agreement's parties, transaction value, financial terms, strategic rationale, or impacts were provided. This mandatory disclosure signals a potentially significant event, but lacks quantitative data for impact assessment.

Aptiv PLC8-Kneutralmateriality 7/10

02-02-2026

Aptiv PLC filed an 8-K on February 2, 2026 (AccNo: 0001521332-26-000004), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

  • Β·Filing size: 1 MB
  • Β·Source: us_sec
  • Β·Sector: NOT_DISCLOSED
Walt Disney Co8-Kneutralmateriality 8/10

02-02-2026

Walt Disney Co filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a standard multi-item earnings-related filing. No specific revenue, earnings, guidance, or period-over-period metrics are detailed in the provided filing summary.

TENET HEALTHCARE CORP8-Kneutralmateriality 7/10

02-02-2026

Tenet Healthcare Corp filed an 8-K on 2026-02-02 (AccNo: 0000070318-26-000003, Size: 381 KB) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative metrics are detailed in the provided information.

Skye Bioscience, Inc.8-Kneutralmateriality 6/10

02-02-2026

Skye Bioscience, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004451, Size: 8 MB) reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely including voluntary material disclosures and attached exhibits. No specific events, financial metrics, transactions, or period-over-period comparisons are disclosed in the provided filing summary.

Sagimet Biosciences Inc.8-Kneutralmateriality 3/10

02-02-2026

Sagimet Biosciences Inc. filed an 8-K on February 02, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, period-over-period comparisons, or quantitative data are disclosed in the filing summary. The disclosure appears informational with exhibits attached, but core event details are NOT_DISCLOSED.

ESAB Corp8-Kneutralmateriality 8/10

02-02-2026

ESAB Corp filed a multi-item Form 8-K on February 02, 2026, disclosing entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, or period-over-period comparisons are disclosed in the provided filing summary. This is an informational filing with potential materiality pending access to full content.

COMERICA INC8-Kneutralmateriality 10/10

02-02-2026

Comerica Inc filed an 8-K on February 2, 2026, disclosing the completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy continued listing rules (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures of directors or officers and elections or appointments (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Item 9.01 references financial statements and exhibits. No quantitative deal terms, parties involved, financial metrics, synergies, or impacts were disclosed.

NRG ENERGY, INC.8-Kneutralmateriality 6/10

02-02-2026

NRG Energy, Inc. filed a Form 8-K on February 02, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information via attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, or performance detailsβ€”positive, negative, or flatβ€”are disclosed in the provided filing information.

TTM TECHNOLOGIES INC8-Kneutralmateriality 5/10

02-02-2026

TTM Technologies Inc filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

REVVITY, INC.8-Kneutralmateriality 8/10

02-02-2026

REVVITY, INC. filed an 8-K on 2026-02-02 disclosing Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed financial data available.

Lumen Technologies, Inc.8-Kneutralmateriality 9/10

02-02-2026

Lumen Technologies, Inc. filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD Disclosure under Item 7.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, values, or performance comparisons are disclosed in the provided filing summary.

  • Β·Accession Number: 0001193125-26-032635
  • Β·File Size: 220 KB
  • Β·Sector: NOT_DISCLOSED
Aquestive Therapeutics, Inc.8-Kneutralmateriality 5/10

02-02-2026

Aquestive Therapeutics, Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001398733-26-000005, size 3 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing provides voluntary public disclosure of potentially material information with attached exhibits. No specific financial metrics, transactions, events, or directional data are disclosed in the filing summary.

AmpliTech Group, Inc.8-Kneutralmateriality 7/10

02-02-2026

AmpliTech Group, Inc. filed a Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, personnel changes, or disclosures provided. No quantitative financial metrics, positive or negative changes, or period-over-period comparisons are disclosed.

Ethos Technologies Inc.8-Kneutralmateriality 7/10

02-02-2026

Ethos Technologies Inc. filed an 8-K on 2026-02-02 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, along with Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, amendments, transaction values, financial impacts, or quantitative metrics are disclosed. This is a multi-item filing with no mentioned positive or negative performance metrics.

VEECO INSTRUMENTS INC8-Kneutralmateriality 3/10

02-02-2026

Veeco Instruments Inc filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events. No specific details on the core event, transaction values, financial metrics, or quantitative data were disclosed in the filing summary. This is a single-item informational disclosure with no directional financial implications evident.

AXCELIS TECHNOLOGIES INC8-Kneutralmateriality 3/10

02-02-2026

Axcels Technologies Inc filed an 8-K on February 2, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive, negative, or flat performance metrics are mentioned.

TYSON FOODS, INC.8-Kneutralmateriality 8/10

02-02-2026

Tyson Foods, Inc. filed an 8-K on February 02, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned. This represents a standard earnings release disclosure without detailed performance data provided.

Eton Pharmaceuticals, Inc.8-Kneutralmateriality 2/10

02-02-2026

Eton Pharmaceuticals, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified metrics, impacts, or directional biases reported.

Spring Valley Acquisition Corp. II8-Kneutralmateriality 5/10

02-02-2026

Spring Valley Acquisition Corp. II, a SPAC, filed an 8-K on 2026-02-02 announcing a Merger/Acquisition event under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are disclosed. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

STAAR SURGICAL CO8-Kneutralmateriality 5/10

02-02-2026

STAAR Surgical Co filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists Financial Statements and Exhibits. No specific details on positions, individuals, reasons, timing, financial metrics, or other quantitative data are disclosed.

HBT Financial, Inc.8-Kneutralmateriality 3/10

02-02-2026

HBT Financial, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 reporting Other Events. No specific details regarding the core event, financial metrics, transaction values, or impacts are disclosed in the provided filing information. No quantitative data, comparisons, or scheduled events are mentioned.

Woodward, Inc.8-Kneutralmateriality 2/10

02-02-2026

Woodward, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 disclosing Other Events and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed. This is a multi-item voluntary filing with no quantitative data or directional implications provided.

New ERA Energy & Digital, Inc.8-Kneutralmateriality 8/10

02-02-2026

New ERA Energy & Digital, Inc. filed a Form 8-K on 2026-02-02 reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, personnel names, or financial metrics disclosed in the provided information. No positive or negative quantitative impacts, period-over-period comparisons, or guidance changes are mentioned.

  • Β·Multi-item 8-K filing dated 2026-02-02 with AccNo: 0001213900-26-010533
  • Β·Size: 1 MB (suggests exhibits present)
  • Β·Sector: NOT_DISCLOSED
VSE CORP8-Kneutralmateriality 3/10

02-02-2026

VSE Corp filed Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events, indicating a material event deemed important by the company, accompanied by Item 9.01 Financial Statements and Exhibits listing attached documents. No specific details on the nature of the other event, transaction values, financial metrics, or exhibits are disclosed in the provided filing metadata. This appears to be a multi-item informational filing with no quantified positive or negative impacts reported.

Anterix Inc.8-Kneutralmateriality 2/10

02-02-2026

Anterix Inc. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events or the content of any exhibits provided in the summary. No quantitative metrics, financial impacts, or strategic details are disclosed.

TYSON FOODS, INC.8-Kneutralmateriality 5/10

02-02-2026

Tyson Foods, Inc. filed an 8-K on February 02, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific core events, financial metrics, transaction details, or quantitative data are disclosed in the provided filing information. This appears to be a multi-item voluntary disclosure focused on information sharing and exhibits.

Twist Bioscience Corp8-Kneutralmateriality 8/10

02-02-2026

Twist Bioscience Corp filed an 8-K on February 2, 2026 (AccNo: 0001581280-26-000016, Size: 293 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing description. This is an informational earnings-related disclosure with no directional performance indicators available.

  • Β·AccNo: 0001581280-26-000016
  • Β·File Size: 293 KB
  • Β·Sector: not specified
Columbia Financial, Inc.8-Kneutralmateriality 5/10

02-02-2026

Columbia Financial, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001723596-26-000004), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or quantitative results such as revenue, earnings, or balance sheet changes are disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits.

STONERIDGE INC8-Kneutralmateriality 7/10

02-02-2026

Stoneridge Inc. filed an 8-K on February 02, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 5.02 changes in directors or certain officers, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, parties involved, or financial terms are disclosed.

HARROW, INC.8-Kneutralmateriality 4/10

02-02-2026

Harrow, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information.

  • Β·Filing Accession Number: 0001493152-26-004635
  • Β·Filing Size: 317 KB
  • Β·Sector: NOT_DISCLOSED
DOW INC.8-Kneutralmateriality 3/10

02-02-2026

DOW INC. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing where specific details of the other events and any attached financial statements or exhibits are NOT_DISCLOSED in the provided information. No quantitative metrics, transactions, or directional impacts are mentioned.

  • Β·AccNo: 0001751788-26-000015
  • Β·File Size: 908 KB
Perspective Therapeutics, Inc.8-Kneutralmateriality 5/10

02-02-2026

Perspective Therapeutics, Inc. filed an 8-K on February 02, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing related to financial results, but specific metrics, transaction details, and performance data are NOT_DISCLOSED. No quantitative financial impacts, period-over-period comparisons, or guidance revisions are provided in the available information.

CLARIVATE PLC8-Kneutralmateriality 8/10

02-02-2026

Clarivate PLC filed a Form 8-K on 2026-02-02 disclosing the termination of a material definitive agreement under Item 1.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No details on the agreement counterparty, termination reasons, financial impacts, or strategic effects were provided. No quantitative metrics, period-over-period comparisons, or performance data were mentioned.

Wave Life Sciences Ltd.8-Kneutralmateriality 4/10

02-02-2026

Wave Life Sciences Ltd. filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-032698), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item informational filing with no evident positive or negative performance indicators.

CLOUDASTRUCTURE, INC.8-Kneutralmateriality 8/10

02-02-2026

Cloudastructure, Inc. filed a Form 8-K on 2026-02-02 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or other quantitative data are provided.

  • Β·Accession Number: 0001683168-26-000646
  • Β·Filing size: 216 KB
QUAINT OAK BANCORP, INC.8-Kneutralmateriality 7/10

02-02-2026

Quaint Oak Bancorp, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0000927089-26-000017), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing for financial results announcement. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are detailed in the provided filing information.

FLEXSTEEL INDUSTRIES INC8-Kneutralmateriality 6/10

02-02-2026

Flexsteel Industries Inc filed a Form 8-K on 2026-02-02 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are provided in the filing information. No positive or negative performance indicators, period-over-period changes, or transaction values are mentioned.

TEXTRON INC8-Kneutralmateriality 3/10

02-02-2026

Textron Inc filed an 8-K on February 02, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

Columbia Financial, Inc.8-Kneutralmateriality 8/10

02-02-2026

Columbia Financial, Inc. filed a Form 8-K on 2026-02-02 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. No positive or negative metrics are mentioned.

Yext, Inc.8-Kneutralmateriality 3/10

02-02-2026

Yext, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 disclosing Other Events. No specific details on the nature of the event, financial metrics, transaction values, or impacts are provided in the filing metadata. This is a single-item voluntary disclosure with no quantitative data or period-over-period comparisons mentioned.

Skyline Bankshares, Inc.8-Kneutralmateriality 5/10

02-02-2026

Skyline Bankshares, Inc. filed a Form 8-K on 2026-02-02 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific quantitative financial metrics, revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other numerical data were explicitly stated in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.

HAIN CELESTIAL GROUP INC8-Kneutralmateriality 7/10

02-02-2026

Hain Celestial Group Inc filed a Form 8-K on February 2, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, disclosures, transaction size, financial impacts, or metrics provided in the available information. No positive, negative, or flat performance metrics are mentioned.

QUANTUM CORP /DE/8-Kneutralmateriality 5/10

02-02-2026

Quantum Corp /DE/ filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Other Events under Item 8.01 and exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or performance comparisons are mentioned.

SIERRA BANCORP8-Kneutralmateriality 7/10

02-02-2026

Sierra Bancorp filed an 8-K on 2026-02-02 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or other quantitative financial details are provided in the filing summary. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

NEW JERSEY RESOURCES CORP8-Kneutralmateriality 7/10

02-02-2026

NEW JERSEY RESOURCES CORP filed an 8-K on February 02, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or period-over-period metrics in the available information. No positive or negative financial changes are detailed, resulting in purely informational disclosure.

DEVON ENERGY CORP/DE8-Kneutralmateriality 8/10

02-02-2026

Devon Energy Corp filed a multi-item 8-K on February 2, 2026, disclosing entry into a Material Definitive Agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No quantitative details, transaction values, personnel names, financial impacts, or performance metrics (positive, negative, or flat) are provided in the filing summary. This requires review of exhibits for full context.

FIRST MERCHANTS CORP8-Kneutralmateriality 4/10

02-02-2026

FIRST MERCHANTS CORP filed a Form 8-K on 2026-02-02 (AccNo: 0000712534-26-000013, Size: 206 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or contents of the exhibits provided. No financial metrics, transactions, or directional impacts are disclosed.

VisionWave Holdings, Inc.8-Kneutralmateriality 5/10

02-02-2026

VisionWave Holdings, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001731122-26-000164, Size: 96 MB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely containing material disclosures and exhibits, but specific details of events, financials, or metrics are NOT_DISCLOSED in the provided information. No quantitative data, performance metrics, positive or negative changes, or directional implications extracted.

Braze, Inc.8-Kneutralmateriality 6/10

02-02-2026

Braze, Inc. filed a Form 8-K on February 2, 2026, disclosing under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws (or change in fiscal year), Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, numerical values, financial impacts, or directional metrics (positive, negative, or flat) are provided in the filing summary. This is a multi-item informational filing with no disclosed transaction values or performance comparisons.

  • Β·AccNo: 0001676238-26-000006
  • Β·Filing size: 180 KB
  • Β·Event date: February 02, 2026
Carter Bankshares, Inc.8-Kneutralmateriality 3/10

02-02-2026

Carter Bankshares, Inc. filed a Form 8-K on February 02, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. All impacts, changes, and scheduled events are NOT_DISCLOSED.

ALLIANCE RESOURCE PARTNERS LP8-Kneutralmateriality 7/10

02-02-2026

Alliance Resource Partners LP filed an 8-K on February 2, 2026 (AccNo: 0001104659-26-008972), reporting under Item 2.02 for results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

Strategy Inc8-Kneutralmateriality 3/10

02-02-2026

Strategy Inc filed a Form 8-K on February 02, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 8.01 Other Events. No specific details, financial metrics, transactions, or scheduled events are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified impacts provided.

Digi Power X Inc.8-Kneutralmateriality 5/10

02-02-2026

Digi Power X Inc. filed an 8-K on February 02, 2026 (AccNo: 0001213900-26-010550, Size: 255 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing includes voluntary disclosure of material information to comply with Regulation FD and attached exhibits, with no specific event details, financial metrics, or quantitative data provided in the filing metadata. No positive or negative metrics are disclosed.

Advanced Biomed Inc.8-Kmixedmateriality 8/10

02-02-2026

Advanced Biomed Inc. filed a Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This multi-item filing signals a potentially strategic transaction alongside possible dilutive equity issuance, but specific terms, values, or impacts remain undisclosed. No quantitative financial metrics, guidance changes, or performance comparisons are provided.

PARK NATIONAL CORP /OH/8-Kneutralmateriality 7/10

02-02-2026

PARK NATIONAL CORP /OH/ filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, parties involved, or impacts are disclosed.

  • Β·Filing Accession Number: 0000805676-26-000010
  • Β·File Size: 481 KB
GIBRALTAR INDUSTRIES, INC.8-Kmixedmateriality 8/10

02-02-2026

Gibraltar Industries, Inc. filed an 8-K on 2026-02-02 reporting entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). The filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), potentially increasing leverage, with Regulation FD disclosure under Item 7.01. No quantitative deal terms, parties, or financial impacts are disclosed.

INNOVATE Corp.8-Kneutralmateriality 3/10

02-02-2026

INNOVATE Corp. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any financial statements or exhibits are disclosed in the provided filing information. This appears to be a multi-item filing with limited disclosure available.

Coterra Energy Inc.8-Kneutralmateriality 8/10

02-02-2026

Coterra Energy Inc. filed a Form 8-K on 2026-02-02 reporting multiple events: entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, personnel names, dollar values, or impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data available.

Tharimmune, Inc.8-Kneutralmateriality 5/10

02-02-2026

Tharimmune, Inc. filed a Form 8-K on February 02, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific vote outcomes, event details, or financial metrics disclosed in the provided information. No positive or negative metrics, changes, or comparisons are mentioned.

Claros Mortgage Trust, Inc.8-Kmixedmateriality 8/10

02-02-2026

Claros Mortgage Trust, Inc. filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement (Item 1.01) alongside termination of another material definitive agreement (Item 1.02). The filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative details, dollar values, or specific impacts were disclosed.

Flowco Holdings Inc.8-Kneutralmateriality 7/10

02-02-2026

Flowco Holdings Inc. filed a Form 8-K on February 02, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potentially significant corporate developments, but lacks substantive content for deeper assessment.

AGILYSYS INC8-Kneutralmateriality 5/10

02-02-2026

Agilysys Inc filed a Form 8-K on February 02, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of material information likely via an attached exhibit such as a press release. This is a multi-item filing with no specific core event, transaction details, financial metrics, or performance comparisons disclosed. No positive or negative metrics are mentioned.

  • Β·AccNo: 0001193125-26-032780
  • Β·Event Type: General Filing
  • Β·Source: us_sec
  • Β·Sector: not specified
TruGolf Holdings, Inc.8-Kneutralmateriality 6/10

02-02-2026

TruGolf Holdings, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001493152-26-004655, Size: 200 KB), reporting solely under Item 8.01 Other Events. No details on the core event, transaction, financial metrics, or impacts are disclosed in the provided information. This single-item filing represents a mandatory disclosure of material information not covered by other 8-K items.

VerifyMe, Inc.8-Kneutralmateriality 4/10

02-02-2026

VerifyMe, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial impacts, transactions, or metrics are disclosed in the provided filing information. This appears to be a multi-item, primarily voluntary disclosure as Item 8.01 covers uncategorized material events.

Cadre Holdings, Inc.8-K/Aneutralmateriality 8/10

02-02-2026

Cadre Holdings, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 the entry into a material definitive agreement. Item 9.01 indicates financial statements and exhibits are included. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed.

BITMINE IMMERSION TECHNOLOGIES, INC.8-Kneutralmateriality 3/10

02-02-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed an 8-K on 2026-02-02 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or other quantitative data are disclosed in the provided filing summary. The disclosure appears informational with attached exhibits.

Northfield Bancorp, Inc.8-Kneutralmateriality 7/10

02-02-2026

Northfield Bancorp, Inc. filed a Form 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, departure/election/appointment of directors/officers and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No specific details on the agreement, personnel changes, financial impacts, transaction values, or quantitative metrics are provided in the filing summary. This is a multi-item informational filing with no disclosed positive or negative financial metrics.

NIQ Global Intelligence plc8-Kneutralmateriality 5/10

02-02-2026

NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.

Empery Digital Inc.8-Kneutralmateriality 2/10

02-02-2026

Empery Digital Inc. filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This appears to be a multi-item informational filing with attached exhibits.

DONALDSON Co INC8-Kneutralmateriality 8/10

02-02-2026

Donaldson Co Inc filed an 8-K on 2026-02-02 reporting under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons, positive or negative metrics, or scheduled events mentioned.

Inuvo, Inc.8-Kneutralmateriality 4/10

02-02-2026

Inuvo, Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001654954-26-000799, Size: 146 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure as Item 8.01 covers company-deemed material events not specified elsewhere. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary.

OPEN TEXT CORP8-Kneutralmateriality 3/10

02-02-2026

Open Text Corp filed an 8-K on 2026-02-02 under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, financial statements, exhibits, transactions, or metrics are disclosed in the provided filing summary. This appears to be an informational disclosure with no quantified positive or negative impacts mentioned.

SIERRA BANCORP8-Kneutralmateriality 2/10

02-02-2026

Sierra Bancorp filed an 8-K on February 2, 2026, reporting under Item 7.01 Regulation FD Disclosure. No specific financial metrics, transactions, events, positive or negative developments, or quantitative data are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

PLUMAS BANCORP8-Kneutralmateriality 5/10

02-02-2026

Plumas Bancorp filed a Form 8-K on February 02, 2026 (AccNo: 0001437749-26-002609, Size: 182 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary. This multi-item filing appears informational with no quantified positive or negative metrics provided.

HUDSON TECHNOLOGIES INC /NY8-Kneutralmateriality 5/10

02-02-2026

Hudson Technologies Inc. (/NY) filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.

KRAKacquisition Corp8-Kneutralmateriality 8/10

02-02-2026

KRAKacquisition Corp filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This filing structure is consistent with a SPAC de-SPAC merger process. No specific transaction parties, values, financial metrics, synergies, or other quantitative details are disclosed.

iPower Inc.8-Kneutralmateriality 8/10

02-02-2026

iPower Inc. filed a Form 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction terms, or financial metrics.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.8-Kneutralmateriality 8/10

02-02-2026

Pacific Biosciences of California, Inc. filed an 8-K on February 02, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. Item 7.01 provides Regulation FD disclosure, and Item 9.01 lists financial statements and exhibits. No specific deal structure, parties, valuation, financial metrics, or impacts are disclosed.

CME GROUP INC.8-Kneutralmateriality 5/10

02-02-2026

CME Group Inc. filed an 8-K on February 2, 2026 (AccNo: 0001156375-26-000002), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, financial metrics, transactions, or events provided in the filing metadata. No quantitative data, positive or negative metrics, or material impacts are mentioned.

BARNWELL INDUSTRIES INC8-Kneutralmateriality 8/10

02-02-2026

Barnwell Industries Inc filed a Form 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details provided on the agreement, modifications, events, transaction values, financial impacts, or quantitative metrics. No positive or negative performance metrics are disclosed.

COLUMBUS MCKINNON CORP8-Kneutralmateriality 6/10

02-02-2026

COLUMBUS MCKINNON CORP filed an 8-K on February 02, 2026 (AccNo: 0001193125-26-032879, Size: 175 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing indicating voluntary public disclosure of material nonpublic information with attached exhibits. No quantitative financial metrics, transactions, positive or negative performance indicators, guidance, or other specific details are disclosed in the filing metadata.

Ondas Holdings Inc.8-Kneutralmateriality 3/10

02-02-2026

Ondas Holdings Inc. filed an 8-K on February 02, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial metrics, or performance comparisons are disclosed in the provided filing summary. Critical content from the exhibits or disclosures is missing, limiting assessment of impact.

OFF THE HOOK YS INC.8-Kneutralmateriality 3/10

02-02-2026

OFF THE HOOK YS INC. filed an 8-K on February 02, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No financial metrics, transactions, guidance, or specific events are detailed in the provided filing information. This is a multi-item filing likely involving voluntary disclosure of material information with attached exhibits.

Agape ATP Corp8-Kneutralmateriality 2/10

02-02-2026

Agape ATP Corp filed a Form 8-K on February 2, 2026, disclosing Item 5.07: Submission of Matters to a Vote of Security Holders. This reports the results of matters submitted to shareholders at a meeting, as required by SEC rules. No specific proposals, vote outcomes, numerical tallies, or other details are provided in the filing summary.

Construction Partners, Inc.8-Kneutralmateriality 3/10

02-02-2026

Construction Partners, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely providing voluntary information such as a press release or presentation as exhibits, with no specific core event, transaction, or financial metrics detailed in the provided filing summary. No positive or negative performance metrics reported.

F&M BANK CORP8-Kneutralmateriality 7/10

02-02-2026

F&M BANK CORP filed an 8-K on February 2, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

GREIF, INC8-Kneutralmateriality 7/10

02-02-2026

Greif, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004695), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, guidance, or other quantitative metrics. No positive or negative performance indicators, scheduled events, or transaction details are mentioned.

ADVANCED DRAINAGE SYSTEMS, INC.8-Kneutralmateriality 5/10

02-02-2026

Advanced Drainage Systems, Inc. filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.

ENB Financial Corp8-Kneutralmateriality 7/10

02-02-2026

ENB Financial Corp filed an 8-K on 2026-02-02 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed.

OPPENHEIMER HOLDINGS INC8-Kneutralmateriality 6/10

02-02-2026

Oppenheimer Holdings Inc filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004480, Size: 2 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing indicates a voluntary disclosure of material information, likely accompanied by exhibits such as a press release or presentation. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed in the filing metadata.

Flutter Entertainment plc8-Kneutralmateriality 3/10

02-02-2026

Flutter Entertainment plc filed a Form 8-K on 2026-02-02 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits, with Accession Number 0001193125-26-033050 and file size 137 KB. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the filing summary. This is a voluntary informational disclosure without apparent positive or negative performance indicators.

CAPITAL CITY BANK GROUP INC8-Kneutralmateriality 5/10

02-02-2026

CAPITAL CITY BANK GROUP INC filed an 8-K on February 02, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves a voluntary disclosure of material non-public information with attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or directional impacts are provided in the filing summary.

INTERNATIONAL BANCSHARES CORP8-Kneutralmateriality 3/10

02-02-2026

International Bancshares Corp filed a Form 8-K on February 02, 2026 (AccNo: 0001104659-26-009083, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, transactions, or directional impacts are mentioned.

AUDDIA INC.8-Kneutralmateriality 3/10

02-02-2026

Auddia Inc. filed a Form 8-K on February 2, 2026, under Item 8.01 'Other Events'. No specific details regarding the nature of the event, financial impacts, transactions, or metrics are disclosed in the provided filing information. No positive or negative developments, scheduled events, or quantitative data are mentioned.

HERITAGE FINANCIAL CORP /WA/8-Kneutralmateriality 8/10

02-02-2026

HERITAGE FINANCIAL CORP /WA/ filed an 8-K on 2026-02-02 under Item 2.01 announcing the completion of an acquisition or disposition of assets. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative deal terms, parties involved, strategic rationale, or financial metrics are disclosed.

Inland Real Estate Income Trust, Inc.8-Kneutralmateriality 3/10

02-02-2026

Inland Real Estate Income Trust, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or governance impacts are mentioned.

E-Smart Corp.8-Kneutralmateriality 3/10

02-02-2026

E-Smart Corp. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, timing, or compensation are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.

OptimumBank Holdings, Inc.8-Kneutralmateriality 7/10

02-02-2026

OptimumBank Holdings, Inc. filed a Form 8-K on 2026-02-02 reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

T Stamp Inc8-Kneutralmateriality 3/10

02-02-2026

T Stamp Inc filed a Form 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or directional financial impacts are mentioned.

SB FINANCIAL GROUP, INC.8-Kneutralmateriality 7/10

02-02-2026

SB Financial Group, Inc. filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing focused on financial results announcement. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided information.

STANDARD MOTOR PRODUCTS, INC.8-Kneutralmateriality 3/10

02-02-2026

STANDARD MOTOR PRODUCTS, INC. filed a Form 8-K on 2026-02-02 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or the nature of the attached financial statements and exhibits are disclosed in the provided filing information. This appears to be an informational disclosure without quantified metrics or directional impacts.

KBS Real Estate Investment Trust III, Inc.8-Kneutralmateriality 8/10

02-02-2026

KBS Real Estate Investment Trust III, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details on the transaction, parties, dollar values, terms, or financial impacts were provided in the filing summary. This multi-item filing appears related to a financing event typical for REITs, with no positive or negative metrics disclosed.

PROVECTUS BIOPHARMACEUTICALS, INC.8-Kneutralmateriality 4/10

02-02-2026

PROVECTUS BIOPHARMACEUTICALS, INC. filed a Form 8-K on 2026-02-02 disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 Financial Statements and Exhibits. No specific details on the nature, effective date, or impact of the amendments or changes are provided. No quantitative financial metrics, positive or negative changes, or other performance data are mentioned.

Regen BioPharma Inc8-Kbearishmateriality 5/10

02-02-2026

Regen BioPharma Inc filed an 8-K on February 2, 2026, specifically under Item 3.02 disclosing unregistered sales of equity securities. No quantitative details such as transaction value, share count, proceeds, or buyer information are disclosed. This is a single-item mandatory filing with no additional positive or negative metrics provided.

Capitol Federal Financial, Inc.8-K/Aneutralmateriality 4/10

02-02-2026

Capitol Federal Financial, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual involved, nature of change (appointment or resignation), reasons, or timing are provided. No quantitative data, financial metrics, or further governance implications are mentioned.

ORION ENERGY SYSTEMS, INC.8-Kneutralmateriality 7/10

02-02-2026

Orion Energy Systems, Inc. filed an 8-K on February 2, 2026, reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This multi-item filing provides limited informational disclosure without quantified data.

Palantir Technologies Inc.8-Kneutralmateriality 7/10

02-02-2026

Palantir Technologies Inc. filed an 8-K on February 02, 2026, reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing likely pertains to financial results or material disclosures but contains no specific numerical data, metrics, or detailed outcomes in the provided summary. No positive, negative, or flat performance indicators are disclosed.

Snowflake Inc.8-Kneutralmateriality 3/10

02-02-2026

Snowflake Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

CAPITAL ONE FINANCIAL CORP8-Kneutralmateriality 3/10

02-02-2026

Capital One Financial Corp filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-033632, Size: 613 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, or exhibits are disclosed. No quantitative metrics, comparisons, or directional impacts are provided.

Axos Financial, Inc.8-Kneutralmateriality 6/10

02-02-2026

Axos Financial, Inc. filed an 8-K on February 02, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing involving voluntary disclosure of material information with attached exhibits. No specific financial metrics, transactions, or events are detailed in the provided filing summary.

CAPITAL SOUTHWEST CORP8-Kneutralmateriality 8/10

02-02-2026

Capital Southwest Corp filed an 8-K on February 02, 2026 (AccNo: 0000017313-26-000010, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided information. No positive or negative performance indicators, period-over-period changes, or material financial impacts are detailed.

Scilex Holding Co8-Kneutralmateriality 8/10

02-02-2026

Scilex Holding Co filed an 8-K on February 2, 2026, disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, or comparisons are disclosed.

DAVITA INC.8-Kneutralmateriality 7/10

02-02-2026

DaVita Inc. filed an 8-K on February 2, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and under Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were mentioned in the filing summary provided. This appears to be a standard earnings-related disclosure without detailed performance data.

NRG ENERGY, INC.8-K/Amateriality 4/10

02-02-2026

Albertsons Companies, Inc.8-Kneutralmateriality 8/10

02-02-2026

Albertsons Companies, Inc. filed an 8-K on 2026-02-02 (AccNo: 0001646972-26-000019) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This is informational with no quantified data provided.

RAMBUS INC8-Kneutralmateriality 7/10

02-02-2026

Rambus Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033624) disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for earnings-related disclosures. No specific revenue, earnings, guidance, balance sheet effects, or other quantitative financial metrics are disclosed in the provided filing information.

Jamf Holding Corp.8-Kmixedmateriality 9/10

02-02-2026

Jamf Holding Corp. disclosed in its 8-K filing on 2026-02-02 the entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). However, the filing also reports creation of direct financial obligations (Item 2.03), triggering events accelerating those obligations (Item 2.04), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to security holders' rights (Item 3.03), changes in control of the registrant (Item 5.01), and departures or elections of directors/officers (Item 5.02), indicating significant but unspecified corporate restructuring with both transactional completion and adverse listing/control changes.

Beyond Air, Inc.8-Kneutralmateriality 2/10

02-02-2026

Beyond Air, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific vote outcomes, numerical metrics, positive or negative changes, or financial details are provided.

HORMEL FOODS CORP /DE/8-Kneutralmateriality 3/10

02-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 2, 2026, disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. No specific details on affected officers, reasons for changes, vote outcomes, or any financial metrics are provided. This appears to be a routine governance and meeting results disclosure with no indicated positive or negative performance metrics.

Petco Health & Wellness Company, Inc.8-Kneutralmateriality 8/10

02-02-2026

Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed.

FRANKLIN FINANCIAL SERVICES CORP /PA/8-Kneutralmateriality 5/10

02-02-2026

FRANKLIN FINANCIAL SERVICES CORP /PA/ filed an 8-K on February 02, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific core event, transaction details, financial metrics, or quantitative data disclosed in the provided filing information. Content of the disclosure and exhibits is NOT_DISCLOSED.

Penguin Solutions, Inc.8-Kneutralmateriality 5/10

02-02-2026

Penguin Solutions, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any names or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

Ventyx Biosciences, Inc.DEFM14Amateriality 4/10

02-02-2026

KFORCE INC8-Kneutralmateriality 5/10

02-02-2026

Kforce Inc filed an 8-K on February 2, 2026 (AccNo: 0000930420-26-000003), reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period changes, or performance details (positive, negative, or flat) are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified data.

PROKIDNEY CORP.8-Kneutralmateriality 3/10

02-02-2026

ProKidney Corp. filed a Form 8-K on February 2, 2026, reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). Specific details of the Regulation FD disclosure, other events, financial statements, or exhibits are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, positive or negative changes, or material events are provided in the filing summary.

FIRST BUSINESS FINANCIAL SERVICES, INC.8-Kneutralmateriality 5/10

02-02-2026

FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

Vaxcyte, Inc.8-Kneutralmateriality 4/10

02-02-2026

Vaxcyte, Inc. filed a Form 8-K on 2026-02-02 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), indicating disclosure of a material event and related exhibits. Specific details of the other events, financial impacts, or metrics are NOT_DISCLOSED in the provided filing summary. No quantitative data, positive or negative metrics, or performance comparisons were mentioned.

MGIC INVESTMENT CORP8-Kneutralmateriality 9/10

02-02-2026

MGIC Investment Corp filed a Form 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a standard voluntary disclosure for financial results with no specific revenue, earnings, or other metrics detailed in the provided filing information. No positive or negative performance indicators, comparisons, or guidance were mentioned.

  • Β·Accession Number: 0000876437-26-000006
  • Β·File Size: 911 KB
  • Β·Sector: not specified
SHORE BANCSHARES INC8-Kneutralmateriality 3/10

02-02-2026

Shore Bancshares Inc filed an 8-K on February 02, 2026 under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, or other quantitative details are disclosed in the filing summary provided. No positive or negative performance indicators are mentioned.

MIRA PHARMACEUTICALS, INC.8-Kneutralmateriality 3/10

02-02-2026

MIRA PHARMACEUTICALS, INC. filed a Form 8-K on February 02, 2026, under Item 8.01 Other Events. No specific details of the event, financial metrics, quantitative data, or period-over-period comparisons are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

PEOPLES BANCORP INC8-Kneutralmateriality 5/10

02-02-2026

Peoples Bancorp Inc filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary filing to disclose material non-public information in compliance with Regulation FD and attach relevant exhibits. No financial metrics, transactions, or other quantitative details are explicitly stated in the filing summary provided.

APPYEA, INC8-Kneutralmateriality 4/10

02-02-2026

APPYEA, INC. filed a Form 8-K on February 02, 2026, disclosing unregistered sales of equity securities under Item 3.02 and attaching financial statements and exhibits under Item 9.01. No details on transaction size, share count, pricing, or parties involved were provided. This is a mandatory disclosure for certain unregistered equity issuances.

Joby Aviation, Inc.8-Kneutralmateriality 8/10

02-02-2026

Joby Aviation, Inc. filed a Form 8-K on 2026-02-02 reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), with Item 9.01 for Financial Statements and Exhibits. This is a multi-item mandatory filing, but specific details on the agreement, financial results, obligation terms, dollar values, or impacts are NOT_DISCLOSED.

Mitesco, Inc.8-Kneutralmateriality 2/10

02-02-2026

Mitesco, Inc. filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. This is a multi-item filing with limited information provided.

Palomar Holdings, Inc.8-Kneutralmateriality 8/10

02-02-2026

Palomar Holdings, Inc. filed an 8-K on February 02, 2026, disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific deal structure, parties, valuation, synergies, or financial impacts are disclosed in the provided filing summary. Critical transaction details remain NOT_DISCLOSED, limiting assessment of shareholder or market implications.

Strategy Inc8-Kneutralmateriality 3/10

02-02-2026

Strategy Inc filed a Form 8-K on February 02, 2026 (AccNo: 0001193125-26-033573, Size: 287 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or contents of the exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantitative financial metrics, transaction details, or directional performance indicators mentioned.

LCNB CORP8-Kneutralmateriality 5/10

02-02-2026

LCNB Corp filed an 8-K on 2026-02-02 under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information to ensure fair disclosure, with exhibits attached under Item 9.01 Financial Statements and Exhibits. No specific transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed in the filing metadata. This is purely informational with no directional financial implications evident.

vTv Therapeutics Inc.8-Kneutralmateriality 8/10

02-02-2026

vTv Therapeutics Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 its entry into a Material Definitive Agreement. No details on the core event, transaction parties, dollar value, financial impacts, or strategic importance are provided in the available information. No quantitative metrics, guidance changes, or scheduled events are mentioned.

TWO HARBORS INVESTMENT CORP.8-Kneutralmateriality 8/10

02-02-2026

Two Harbors Investment Corp. filed an 8-K on February 2, 2026 (AccNo: 0001465740-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing announcing financial results with attached exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.

GENELUX Corp8-Kneutralmateriality 6/10

02-02-2026

GENELUX Corp filed an 8-K on February 02, 2026 (AccNo: 0001493152-26-004755, size: 40 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information pursuant to Regulation FD with attached exhibits, but no specific transaction details, financial metrics, or events are stated in the provided summary. No quantitative data, period-over-period comparisons, or directional metrics (positive, negative, or flat) are mentioned.

FEDERAL AGRICULTURAL MORTGAGE CORP8-Kneutralmateriality 4/10

02-02-2026

FEDERAL AGRICULTURAL MORTGAGE CORP filed an 8-K on February 02, 2026, reporting amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, with financial statements and exhibits provided under Item 9.01. No specific details on the nature or impact of the amendments, quantitative metrics, transaction values, or financial implications are disclosed in the filing summary. This appears to be an informational governance update with no directional financial data provided.

CENTURY ALUMINUM CO8-Kneutralmateriality 9/10

02-02-2026

Century Aluminum Co filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific transaction details, parties, values, or financial metrics are disclosed.

Simply Good Foods Co8-Kneutralmateriality 5/10

02-02-2026

Simply Good Foods Co filed an 8-K on 2026-02-02 disclosing an officer change or director departure/election under Item 5.02, including compensatory arrangements. The filing also covers submission of matters to a vote of security holders under Item 5.07 and financial statements/exhibits under Item 9.01. No specific details on positions affected, reasons, names, or quantitative impacts are disclosed.

FIRST FINANCIAL BANCORP /OH/8-Kneutralmateriality 5/10

02-02-2026

FIRST FINANCIAL BANCORP /OH/ filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 9 MB. No specific financial metrics, transactions, positive or negative changes, or operational details are disclosed in the provided filing summary. This appears to be a voluntary disclosure to comply with Regulation FD, potentially including attached exhibits such as presentations.

  • Β·AccNo: 0000708955-26-000011
  • Β·Filing size: 9 MB
  • Β·Event Type: General Filing
  • Β·Multi-item 8-K: Items 7.01 and 9.01
XCEL ENERGY INC8-Kneutralmateriality 7/10

02-02-2026

XCEL ENERGY INC filed an 8-K on 2026-02-02 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), indicating a new financing-related agreement. Item 9.01 includes Financial Statements and Exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

SIMON PROPERTY GROUP INC.8-Kneutralmateriality 7/10

02-02-2026

Simon Property Group Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-009209), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED. No positive, negative, or flat performance indicators are provided in the filing details.

ONITY GROUP INC.8-Kneutralmateriality 8/10

02-02-2026

Onity Group Inc. filed an 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

Braemar Hotels & Resorts Inc.8-Kneutralmateriality 4/10

02-02-2026

Braemar Hotels & Resorts Inc. filed an 8-K on February 2, 2026 (AccNo: 0001574085-26-000013, Size: 367 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are explicitly stated in the filing summary provided. This appears to be a voluntary disclosure with attached materials, but core event details are NOT_DISCLOSED.

NELNET INC8-Kneutralmateriality 3/10

02-02-2026

Nelnet Inc filed an 8-K on February 2, 2026, under Item 8.01 disclosing Other Events. No specific details regarding the nature of the events, financial impacts, quantitative metrics, or strategic implications are provided in the filing summary. No positive or negative metrics are mentioned.

TERAWULF INC.8-Kneutralmateriality 5/10

02-02-2026

TERAWULF INC. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed. This is a multi-item filing with no quantitative metrics, positive or negative developments, or directional implications provided.

AMKOR TECHNOLOGY, INC.8-Kneutralmateriality 4/10

02-02-2026

AMKOR TECHNOLOGY, INC. filed an 8-K on 2026-02-02 (AccNo: 0001047127-26-000003, Size: 138 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, effective dates, or internal/external nature are provided. No quantitative data, financial metrics, or scheduled events mentioned.

Sky Quarry Inc.8-Kneutralmateriality 4/10

02-02-2026

Sky Quarry Inc. filed an 8-K on 2026-02-02 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.

ZYNEX INC8-Kbearishmateriality 10/10

02-02-2026

ZYNEX INC filed a Form 8-K on 2026-02-02 under Item 1.03 disclosing Bankruptcy or Receivership. No financial metrics, transaction values, dollar amounts, or other quantitative details are provided in the filing summary. This represents a material negative event with no offsetting positive disclosures.

Greenland Technologies Holding Corp.8-Kneutralmateriality 7/10

02-02-2026

Greenland Technologies Holding Corp. filed a Form 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.07 submission of matters to a vote of security holders, with Item 9.01 providing financial statements and exhibits. No specific details, dollar values, vote outcomes, or quantitative financial impacts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

Bally's Corp8-Kneutralmateriality 6/10

02-02-2026

Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

FIRST UNITED CORP/MD/8-Kneutralmateriality 5/10

02-02-2026

FIRST UNITED CORP/MD/ filed an 8-K on 2026-02-02 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. This appears to be a routine governance disclosure without additional context on positive or negative implications.

NightFood Holdings, Inc.8-Kneutralmateriality 3/10

02-02-2026

NightFood Holdings, Inc. filed an 8-K on February 02, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are explicitly stated in the filing summary. No quantitative data, period-over-period comparisons, or material events are disclosed.

NORDSON CORP8-Kneutralmateriality 7/10

02-02-2026

Nordson Corp filed an 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No specific details, dollar values, terms, or impacts are disclosed in the provided filing summary.

S&T BANCORP INC8-Kneutralmateriality 3/10

02-02-2026

S&T Bancorp Inc filed an 8-K on February 2, 2026, reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or period-over-period comparisons are disclosed in the provided filing information.

KADANT INC8-Kneutralmateriality 3/10

02-02-2026

Kadant Inc. filed an 8-K on February 2, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing information. The nature of the Regulation FD disclosure and contents of exhibits are NOT_DISCLOSED.

EVERTEC, Inc.8-Kneutralmateriality 8/10

02-02-2026

EVERTEC, Inc. filed a Form 8-K on 2026-02-02 disclosing Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing covering a core material event with attached exhibits. No specific details on the agreement terms, financial impacts, or quantitative metrics are disclosed in the provided information.

EMPIRE PETROLEUM CORP8-Kneutralmateriality 4/10

02-02-2026

Empire Petroleum Corp filed a Form 8-K on February 02, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are explicitly stated in the filing summary. This appears to be a multi-item filing focused on voluntary disclosure of potentially material information.

Janus International Group, Inc.8-Kneutralmateriality 8/10

02-02-2026

Janus International Group, Inc. filed a Form 8-K on 2026-02-02 disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing indicating significant corporate developments involving a new agreement and financial commitment. No specific transaction details, dollar values, or financial impacts are disclosed.

Third Coast Bancshares, Inc.8-Kneutralmateriality 8/10

02-02-2026

Third Coast Bancshares, Inc. filed an 8-K on February 2, 2026, disclosing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, along with Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No quantitative metrics, transaction details, or performance comparisons are explicitly stated.

FiEE, Inc.8-Kneutralmateriality 8/10

02-02-2026

FiEE, Inc. filed a multi-item Form 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, dollar values, share counts, or performance comparisons (positive, negative, or flat) were disclosed in the provided filing summary. This disclosure signals potentially significant developments but lacks quantification for impact assessment.

GOLDMAN SACHS GROUP INC8-Kneutralmateriality 1/10

02-02-2026

Goldman Sachs Group Inc filed an 8-K on February 2, 2026, solely under Item 9.01 Financial Statements and Exhibits, indicating attachment of unspecified financial statements or exhibits (file size 344 KB). No specific events, transactions, metrics, or details are disclosed in the filing summary. This appears to be an informational exhibit filing with no directional financial impact evident.

Sezzle Inc.8-Kneutralmateriality 7/10

02-02-2026

Sezzle Inc. filed an 8-K on February 02, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, or guidance were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure.

BELLRING BRANDS, INC.8-Kneutralmateriality 3/10

02-02-2026

BellRing Brands, Inc. filed an 8-K on February 2, 2026 (AccNo: 0001628280-26-004642), reporting under Item 5.07 the submission of matters to a vote of security holders. No specific proposals, vote results, numerical outcomes, or other details are disclosed in the provided filing information. This is a standard informational disclosure on shareholder meeting votes with no financial metrics or directional implications mentioned.

UNITED STATES LIME & MINERALS INC8-Kneutralmateriality 5/10

02-02-2026

UNITED STATES LIME & MINERALS INC filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the filing summary. Sector information is not specified.

Veradigm Inc.8-Kneutralmateriality 8/10

02-02-2026

Veradigm Inc. filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific details on the agreement, modifications, or disclosures are provided in the filing summary. No quantitative financial impacts, positive or negative metrics, or period-over-period comparisons are disclosed.

Bark, Inc.8-Kneutralmateriality 3/10

02-02-2026

Bark, Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004626), disclosing an unspecified event under Item 8.01 (Other Events). No financial metrics, transaction details, quantitative data, positive or negative changes, or operational impacts were mentioned. Sector information was not specified.

Atlas Energy Solutions Inc.8-Kneutralmateriality 3/10

02-02-2026

Atlas Energy Solutions Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or any quantitative impacts were mentioned. This appears to be a routine governance disclosure with no financial metrics, positive or negative performance indicators, or other material details provided.

Encompass Health Corp8-Kneutralmateriality 4/10

02-02-2026

Encompass Health Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

Goldman Sachs BDC, Inc.8-Kneutralmateriality 8/10

02-02-2026

Goldman Sachs BDC, Inc. filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

DAKTRONICS INC /SD/8-Kneutralmateriality 5/10

02-02-2026

DAKTRONICS INC /SD/ filed an 8-K on 2026-02-02 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits accompany the filing. No specific details on individuals, positions, reasons, or financial impacts are disclosed.

PROSPERITY BANCSHARES INC8-Kneutralmateriality 3/10

02-02-2026

Prosperity Bancshares Inc filed an 8-K on February 2, 2026, reporting under Item 8.01 Other Events, which covers material events not specified in other items, and Item 9.01 Financial Statements and Exhibits, indicating attached documents such as press releases or agreements. No specific details on the nature of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is an informational filing with no quantitative data or directional implications available.

MIDDLEBY Corp8-Kneutralmateriality 4/10

02-02-2026

MIDDLEBY Corp filed an 8-K on 2026-02-02 (AccNo: 0001193125-26-033775, Size: 165 KB) under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

XOMA Royalty Corp8-K/Aneutralmateriality 7/10

02-02-2026

XOMA Royalty Corp filed an 8-K on 2026-02-02 disclosing the completion of an acquisition or disposition of assets under Item 2.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on transaction parties, structure, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are provided.

Installed Building Products, Inc.8-Kneutralmateriality 4/10

02-02-2026

Installed Building Products, Inc. filed a Form 8-K on February 02, 2026 (AccNo: 0001628280-26-004634), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific quantitative metrics, transactions, or operational details disclosed in the provided summary. No positive or negative financial changes, guidance, or events are mentioned.

DarioHealth Corp.8-Kneutralmateriality 3/10

02-02-2026

DarioHealth Corp. filed a Form 8-K on February 2, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the amendments' nature, impacts, or strategic implications were provided.

Profusa, Inc.8-Kneutralmateriality 3/10

02-02-2026

Profusa, Inc. filed an 8-K on February 2, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders following a shareholder meeting. No specific proposals, vote results, or numerical outcomes are disclosed in the provided filing summary. This is a standard post-meeting informational disclosure with no financial or operational metrics reported.

APARTMENT INVESTMENT & MANAGEMENT CO8-Kneutralmateriality 2/10

02-02-2026

APARTMENT INVESTMENT & MANAGEMENT CO filed a Form 8-K on February 02, 2026, disclosing an unspecified Other Event under Item 8.01. No quantitative data, financial impacts, transaction details, or other metrics are mentioned in the filing information provided. This is a voluntary single-item disclosure with no further specifics on the event.

Vicarious Surgical Inc.8-Kneutralmateriality 4/10

02-02-2026

Vicarious Surgical Inc. filed an 8-K on 2026-02-02 disclosing an unspecified officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included, but specific details are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or directional impacts are provided in the filing summary.

Newbridge Acquisition Ltd8-Kneutralmateriality 8/10

02-02-2026

Newbridge Acquisition Ltd filed an 8-K on 2026-02-02 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger or acquisition, along with unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or performance comparisons (positive, negative, or flat) are disclosed. Critical details such as target company, deal structure, consideration, and timeline remain NOT_DISCLOSED.

Avidia Bancorp, Inc.8-Kneutralmateriality 5/10

02-02-2026

Avidia Bancorp, Inc. filed an 8-K on February 2, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.

Quince Therapeutics, Inc.8-Kneutralmateriality 5/10

02-02-2026

Quince Therapeutics, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are provided. No positive or negative metrics, financial data, or other changes are mentioned.

Petco Health & Wellness Company, Inc.8-Kneutralmateriality 4/10

02-02-2026

Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure. No specific details on the officer name, position, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

COMMUNITY HEALTH SYSTEMS INC8-Kneutralmateriality 7/10

02-02-2026

Community Health Systems Inc filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. Item 8.01 discloses other events, and Item 9.01 provides financial statements and exhibits. No specific details on transaction parties, value, structure, or financial impacts are disclosed.

Element Solutions Inc8-Kneutralmateriality 7/10

02-02-2026

Element Solutions Inc filed an 8-K on 2026-02-02 disclosing Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, financial obligation, dollar values, strategic impacts, or metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data available.

BrooQLy Inc.8-Kneutralmateriality 4/10

02-02-2026

BrooQLy Inc. filed a Form 8-K on February 02, 2026, under Item 5.03 disclosing amendments to Articles of Incorporation or Bylaws or a change in fiscal year, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. No specific details, numerical values, transaction sizes, or financial impacts are disclosed in the filing summary. This is a multi-item informational filing with no directional metrics provided.

Walker & Dunlop, Inc.8-Kneutralmateriality 7/10

02-02-2026

Walker & Dunlop, Inc. filed an 8-K on February 02, 2026 (AccNo: 0001104659-26-009264), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial impacts, or other metrics are provided.

UNITIL CORP8-Kneutralmateriality 7/10

02-02-2026

Unitil Corp filed an 8-K on February 2, 2026, reporting entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, personnel names, transaction sizes, or financial impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no quantified positive or negative metrics available.

FARMERS & MERCHANTS BANCORP8-Kneutralmateriality 6/10

02-02-2026

Farmers & Merchants Bancorp filed a Form 8-K on February 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely providing material non-public information previously disclosed selectively, with supporting exhibits attached. No specific financial metrics, transactions, or performance details are disclosed in the filing summary.

FARMERS & MERCHANTS BANCORP8-Kneutralmateriality 5/10

02-02-2026

Farmers & Merchants Bancorp filed an 8-K on February 2, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the filing details. This appears to be a standard earnings-related disclosure without quantified metrics.

LEXICON PHARMACEUTICALS, INC.8-Kneutralmateriality 8/10

02-02-2026

Lexicon Pharmaceuticals, Inc. filed a Form 8-K on February 2, 2026, reporting multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, share counts, or directional impacts were disclosed. The filing appears informational without quantified positive or negative metrics.

RCI HOSPITALITY HOLDINGS, INC.8-Kbearishmateriality 10/10

02-02-2026

RCI Hospitality Holdings, Inc. filed Form 8-K on 2026-02-02 under Item 3.01 announcing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 discloses Financial Statements and Exhibits. No specific reasons, timelines, financial impacts, or quantitative details are provided.

Triller Group Inc.8-Kneutralmateriality 6/10

02-02-2026

Triller Group Inc. filed a Form 8-K on February 02, 2026, reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No specific details, quantitative impacts, reasons for the change, or financial metrics are provided.

SIMMONS FIRST NATIONAL CORP8-K/Aneutralmateriality 3/10

02-02-2026

SIMMONS FIRST NATIONAL CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the individuals involved, positions affected, reasons for the change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.

EVERSPIN TECHNOLOGIES INC.8-Kneutralmateriality 2/10

02-02-2026

EverSpin Technologies Inc. filed a Form 8-K on February 2, 2026 (AccNo: 0001628280-26-004681, Size: 142 KB), reporting under Item 8.01 Other Events. No specific details on the nature of the event, financial metrics, transactions, or impacts are disclosed. No positive, negative, or flat performance metrics are mentioned.

AIxCrypto Holdings, Inc.8-Kneutralmateriality 7/10

02-02-2026

AIxCrypto Holdings, Inc. filed an 8-K on 2026-02-02 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, or directional impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantified positive or negative metrics available.

Esquire Financial Holdings, Inc.8-Kneutralmateriality 2/10

02-02-2026

Esquire Financial Holdings, Inc. filed an 8-K on February 2, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the exhibits are provided. This appears to be a voluntary informational filing with no quantified financial metrics or directional impacts disclosed.

Lazard, Inc.8-Kneutralmateriality 4/10

02-02-2026

Lazard, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, named executives, or scheduled events are mentioned.

TEREX CORP8-Kneutralmateriality 8/10

02-02-2026

Terex Corp filed an 8-K on 2026-02-02 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also reports departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, along with other events under Item 8.01. Financial statements and exhibits are included under Item 9.01; no specific transaction details, financial metrics, or performance changes are disclosed.

BLACKLINE, INC.8-Kneutralmateriality 3/10

02-02-2026

BlackLine, Inc. filed a Form 8-K on February 2, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing summary.

ARMSTRONG WORLD INDUSTRIES INC8-Kneutralmateriality 3/10

02-02-2026

Armstrong World Industries Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033816, Size: 154 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector is not specified.

  • Β·Filing Accession Number: 0001193125-26-033816
  • Β·Filing Size: 154 KB
HF Foods Group Inc.8-Kneutralmateriality 3/10

02-02-2026

HF Foods Group Inc. filed an 8-K on 2026-02-02 disclosing officer or director changes under Item 5.02, which includes departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were provided.

NRX Pharmaceuticals, Inc.8-Kneutralmateriality 3/10

02-02-2026

NRX Pharmaceuticals, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any quantitative metrics are provided. No positive or negative performance metrics are mentioned.

CHEMUNG FINANCIAL CORP8-Kneutralmateriality 3/10

02-02-2026

Chemung Financial Corp filed an 8-K on 2026-02-02 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary release of material information with attached documents. The filing size is 8 MB, suggesting possible press releases, presentations, or financial exhibits. No specific transaction details, financial metrics, positive or negative changes, or events are disclosed in the provided information.

Atkore Inc.8-Kneutralmateriality 2/10

02-02-2026

Atkore Inc. filed an 8-K on February 2, 2026, under Item 5.07 reporting the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or compensation approvals. Item 9.01 discloses financial statements and exhibits were attached. No vote outcomes, numerical results, financial metrics, or directional impacts provided in the filing details.

MDB Capital Holdings, LLC8-Kneutralmateriality 4/10

02-02-2026

MDB Capital Holdings, LLC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

SunPower Inc.8-Kneutralmateriality 7/10

02-02-2026

SunPower Inc. filed an 8-K on 2026-02-02 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and attaches financial statements and exhibits (Item 9.01). No specific transaction details, parties, values, or metrics are disclosed.

OLYMPIC STEEL INC8-Kneutralmateriality 1/10

02-02-2026

Olympic Steel Inc filed an 8-K on February 2, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the core event, financial impacts, transactions, metrics, or scheduled events are disclosed. This is a voluntary, single-item informational filing with no quantitative data provided.

ASHLAND INC.8-Kneutralmateriality 5/10

02-02-2026

Ashland Inc. filed an 8-K on February 2, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data were disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, but lacks detailed performance data for analysis.

Mawson Infrastructure Group Inc.8-Kneutralmateriality 8/10

02-02-2026

Mawson Infrastructure Group Inc. filed an 8-K on 2026-02-02 reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing indicates significant corporate governance and agreement changes, but lacks context to assess positive or negative implications.

Dayforce, Inc.8-Kneutralmateriality 3/10

02-02-2026

Dayforce, Inc. filed an 8-K on February 02, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the filing metadata. This appears to be a multi-item informational filing with no quantified financial metrics or directional indicators provided.

INTERNATIONAL BUSINESS MACHINES CORP8-Kneutralmateriality 1/10

02-02-2026

International Business Machines Corp (IBM) filed an 8-K on February 2, 2026, solely under Item 9.01: Financial Statements and Exhibits. No specific financial metrics, transactions, period-over-period comparisons, or material events are disclosed in the filing details provided. This is an informational filing with attached exhibits but lacks quantitative data or directional impacts.

STONERIDGE INC8-Kneutralmateriality 5/10

02-02-2026

STONERIDGE INC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any quantitative data are NOT_DISCLOSED. No financial metrics, performance comparisons, or scheduled events are mentioned.

SPX Technologies, Inc.8-Kneutralmateriality 5/10

02-02-2026

SPX Technologies, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, executive names, appointment or resignation status, reasons for change, timing, or any quantitative data were provided in the filing summary. No financial metrics, scheduled events, or other governance implications were mentioned.

IMMUCELL CORP /DE/8-Kneutralmateriality 8/10

02-02-2026

ImmuCell Corp filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 discloses financial statements and exhibits. No specific transaction details, personnel names, financial impacts, dollar values, or quantitative metrics are disclosed.

DALRADA FINANCIAL CORP8-K/Aneutralmateriality 8/10

02-02-2026

DALRADA FINANCIAL CORP filed an 8-K on February 2, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, terms, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

Shuttle Pharmaceuticals Holdings, Inc.8-Kneutralmateriality 3/10

02-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

Blackwell 3D Construction Corp.8-Kneutralmateriality 8/10

02-02-2026

Blackwell 3D Construction Corp. filed a Form 8-K on 2026-02-02 reporting Item 5.06, announcing a change in shell company status. This indicates the company is no longer classified as a shell company. No financial metrics, transaction details, or other quantitative data were disclosed.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 258 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
S&P 500 Financials Sector SEC Filings β€” February 01, 2026 | Gunpowder Blog